Hypercalcemia and hyperphosphatemia associate with an elevated risk of cardiovascular
events, yet the pathophysiological basis of this association is unclear. Disturbed mineral …

Dietary habits in the western world lead to increasing phosphate intake. Under physiological
conditions, extraosseous precipitation of phosphate with calcium is prevented by a mineral …

Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney
disease (CKD). Multiple factors account for the increased incidence of cardiovascular …

The precise toxico-pathogenic effects of zinc oxide nanoparticles (ZnO-NPs) on the
cardiovascular system under normal and cardiovascular disease (CVD) risk factor milieu are …

Objective: Vascular calcification contributes to the cause of cardiovascular disease. The
calciprotein particle maturation time (T50) in serum, a measure of calcification propensity …

Deregulations in gut microbiota may play a role in vascular and bone disease in chronic
kidney disease (CKD). As glomerular filtration rate declines, the colon becomes more …

Awareness of the clinical relevance of magnesium in medicine has increased over the last
years, especially for people with chronic kidney disease (CKD), due to magnesium's role in …

Abstract Two decades ago, Kidney Disease: Improving Global Outcomes coined the term
chronic kidney disease–mineral and bone disorder (CKD–MBD) to describe the syndrome of …

Vascular calcification (VC), characterized by different mineral deposits (ie, carbonate apatite,
whitlockite and hydroxyapatite) accumulating in blood vessels and valves, represents a …

Increasing evidence has suggested a clinical relevance of magnesium in the context of
vascular calcification and mortality among patients with CKD. Hypomagnesemia is not rare …